Bivariate microarray analysis: statistical interpretation of two-channel functional genomics data by Hsiao, Albert & Subramaniam, Shankar
RESEARCH ARTICLE
Bivariate microarray analysis: statistical interpretation
of two-channel functional genomics data
Albert Hsiao Æ Shankar Subramaniam
Received: 5 October 2006/Revised: 11 July 2009/Accepted: 13 July 2009/Published online: 13 August 2009
 The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract Conventionalstatisticalmethodsforinterpreting
microarray data require large numbers of replicates in order
to provide sufﬁcient levels of sensitivity. We recently
described a method for identifying differentially-expressed
genes in one-channel microarray data 1. Based on the idea
that the variance structure of microarray data can itself be a
reliable measure of noise, this method allows statistically
soundinterpretationofasfewastworeplicatespertreatment
condition. Unlike the one-channel array, the two-channel
platform simultaneously compares gene expression in two
RNA samples. This leads to covariation of the measured
signals.Hence,byaccountingforcovariationinthevariance
model, we can signiﬁcantly increase the power of the sta-
tisticaltest.Webelievethatthisapproachhasthepotentialto
overcomelimitationsofexistingmethods.Wepresentherea
novel approach for the analysis of microarray data that
involves modeling the variance structure of paired expres-
sion data in the context of a Bayesian framework. We also
describe a novel statistical test that can be used to identify
differentially-expressed genes. This method, bivariate
microarray analysis (BMA), demonstrates dramatically
improvedsensitivityoverexistingapproaches.Weshowthat
with only two array replicates, it is possible to detect gene
expression changes that are at best detected with six array
replicates by other methods. Further, we show that com-
bining results from BMA with Gene Ontology annotation
yields biologically signiﬁcant results in a ligand-treated
macrophage cell system.
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Abbreviations
BMA Bivariate microarray analysis
VAMPIRE Variance-modeled posterior inference with
regional exponentials
FDR False discovery rate
RMSD Root mean square deviation
AfCS Alliance for cellular signaling
GO Gene ontology
KEGG Kyoto encyclopedia of genes and genomes
MHC Major histocompatibility complex
LPS Lipopolysaccharide
Introduction
Microarrays are invaluable tools for measuring transcrip-
tional responses of cells and tissues. The most common and
perhaps the most fundamental question that is asked is
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tistically signiﬁcant. Traditionally, a fold-change cutoff has
been used as an indicator of signiﬁcance. Although fold-
change can be a consistent measure at high signal inten-
sities, it is not very reliable when the signals are low. Low
intensities are therefore ﬁltered out prior to applying a fold
change threshold, leaving these genes poorly interpreted.
More rigorous statistical techniques are therefore desired to
overcome these limitations.
The variance structure of microarray data has been
widely known and modeled by a number of groups (Ideker
et al. 2000; Li and Wong 2001; Rocke and Durbin 2001). It
is believed that this variance structure can be decomposed
into an expression-dependent and an expression-indepen-
dent component. The approaches generally taken however,
have been to ‘‘normalize’’ the microarray data to remove
this undesired behavior, and process the resultant data with
existing statistical tests (Sasik et al. 2002; Durbin and
Rocke 2004; Irizarry et al. 2003). We have taken a fun-
damentally different approach to this problem. Recogniz-
ing that the sample variance is itself a poor estimator of
noise at low replicate numbers (n = 2–3), we hypothesized
that the variance structure itself could be used as a more
precise estimator of variance (Hsiao et al. 2004). We
subsequently devised a modeling procedure to identify the
maximum likelihood estimates of expression-dependent
and expression-independent variance. This model was then
incorporated directly into a Bayesian statistical test.
In addition to normalization strategies, several statistical
methods have been described to interpret gene expression
data. Non-parametric methods such as Signiﬁcance Anal-
ysis of Microarrays (SAM) (Tusher et al. 2001) are widely
applicable because they do not rely on explicit assumptions
about the error structure. These non-parametric methods,
however, lack sensitivity in the absence of high levels of
replication. On the other hand, parametric methods such as
the t-test and Bayesian variants like Cyber-T (Baldi and
Long 2001) can be powerful because of their ability to
extrapolate the behavior of variability based on prior
assumptions about the error structure. By parameterization,
these methods reduce the minimum number of array rep-
licates needed to identify signiﬁcant changes in gene
expression. Despite these advances however, existing
methods still require many replicates to achieve sufﬁcient
sensitivity for biological interpretation.
We present a novel statistical approach for the inter-
pretation of microarray functional genomics data that can
be performed on as few as one measurement per experi-
mental condition. Our method, the BMA (Bivariate
Microarray Analysis) is based on the Bayesian framework
developed in Hsiao et al. (2004) for the interpretation of
one-channel array data. In addition to modeling the rela-
tionship between signal intensity and variance, BMA also
models the covariation between the two color channels. We
demonstrate in simulated data the dramatically increased
sensitivity of BMA over other standard approaches, par-
ticularly at low replicate numbers (n = 2). This remains
true independent of whether we choose an array-wide
false-positive rate (aBonf) or a false discovery rate (FDR) as
a signiﬁcance threshold. Lastly, we show that when BMA
is applied to a time course study of lipopolysaccharide
(LPS)-treated macrophages, the differential gene expres-
sion pattern found with a single dye-swapped pair is very
similar to that detected with three dye-swap pairs.
Statistics and modeling
Bayesian framework
The mean of intensity measurements is typically used as a
point estimate for gene expression and the variance from
that mean is used as an indicator of variability. Our method
relies on the notion that a model that ﬁts the error structure
of microarray data will be a better estimator of variability.
By integrating this variance model into a Bayesian
framework, which is discussed more thoroughly in Sup-
porting Information Sect. I, we transform the mean inten-
sity into a probability density for gene expression. The
resulting probability density describes the likely values for
‘‘true expression level’’ (l). We can then apply statistical
tests on this density to determine which genes are differ-
entially-expressed between two experimental conditions.
The foundation of our approach, then, lies at accurately
modeling the amount of noise in microarray data.
The error structure of microarray data
Microarray gene expression data displays greater fractional
error at low signal intensities than at high intensities. When
the same RNA samples are analyzed on multiple arrays,
this relationship is still present, indicating that much of this
variation comes from the microarray platform itself. We
believe that platform-speciﬁc factors, such as the resolution
of the microscope and dye system, fundamentally limit the
reliability of low-intensity measurements. We refer to this
type of noise as expression-independent variance (B). At
greater signal intensities, this physical limit becomes less
and less important. Here, expression-dependent variance
(A) begins to dominate, but both kinds of error are small
compared to the signal. By itself, this simple model can
explain much of the variance behavior in a single channel.
In a two-channel microarray, measurements are
obtained from two RNA samples labeled with different
dyes. These samples are subsequently hybridized with the
microarray probes (Brown and Botstein 1999). Since these
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123probes are spotted, rather than synthesized directly on the
array surface, there can be considerable variability between
the amounts of probe spotted between arrays. This varia-
tion in ‘‘probe intensity’’ alters the intensity measurements
for both color channels, and leads to covariation of the
paired signals. We therefore chose to model this covaria-
tion by introducing correlation coefﬁcients for expression-
dependent and expression-independent variance. The ﬁnal
variance model contains a total of six parameters. These
parameters are related to the treatment variances (r1, r2)
and correlation (q) through:
r2
1 ¼ l2
1A1 þ B1 ð1Þ
r2
2 ¼ l2
2A2 þ B2 ð2Þ
qr1r2 ¼ qAl1l2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
A1A2
p
þ qB
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
B1B2
p
ð3Þ
where (A1, A2) are the expression-dependent variances, (B1,
B2) are the expression-independent variances, qA is the
expression-dependent correlation, qB is the expression-
independent correlation, and l1, l2 are the ‘‘true’’ expres-
sion level of each treatment condition.
Parameter estimation
Parameters for the variance model can be computed by
Markov Chain Monte Carlo (MCMC) simulation of the
bivariate normal density. This simulation computes the
maximum likelihood estimates for each of the six variance
parameters. Since the ‘‘true’’ gene expression is not known
prior to observing array measurements, the observed sam-
ple mean is used as a surrogate. This choice, although
necessary, can be problematic at low intensities. With the
sample mean as a surrogate for true expression, poor sig-
nal-to-noise ratios can cause underestimation of true vari-
ability. Therefore, we have devised an estimation technique
that identiﬁes parameters which are stable against an
expression-level cutoff.
Model parameters should be the same regardless of how
much data is used to estimate them. Thus, we may pro-
gressively discard increasing numbers of low-intensity
features to avoid the downward bias caused by low signal-
to-noise. In Fig. 1, we demonstrate the effect of these
cutoffs on estimates of expression-independent error. This
parameter has two regions that are relatively stable against
successive quantile cutoffs. When smaller cutoffs are used,
expression-independent error tends to be underestimated.
When larger cutoffs are used, the parameters become
unstable. The details of the modeling procedure are dis-
cussed in Supporting Information Sect. II. It is also
important to note that the expression-level cutoff deﬁned
here is only used to improve the quality of parameter
estimates. The resulting variance model is applied across
the entire array. By combining this model with the
Bayesian framework described earlier, we can then use a
statistical test to determine the signiﬁcance of observed
differences in gene expression.
Statistical test
In order to make BMA compatible with conventional
concepts widely understood by the biological research
community, we devised a statistical test that computes a
P-value. This P-value may be used to control type I error,
which is the rate at which the null hypothesis is incorrectly
rejected. In BMA, we deﬁne the null hypothesis (H0)t ob e
that the ‘‘true’’ gene expression does not change across two
experimental conditions. The alternative hypothesis (H1)i s
accepted when the null hypothesis is rejected. In other
words, we test
H0 : l2   l1 jj ¼ 0 against H1 : l2   l1 jj 6¼ 0 ð4Þ
where l1 and l2 represent the ‘‘true’’ expression of the two
treatment conditions.
The P-value of BMA is deﬁned in a way similar to that
of a t-test. In a t-test, the P-value is deﬁned as an integral of
a t-distribution. When the ‘‘tail area’’ of the t-distribution is
sufﬁciently small, we consider experimental results to be
statistically signiﬁcant. In BMA, we deﬁne the P-value as a
two-dimensional integral of a bivariate normal density. In
other words, we determine whether the ‘‘tail volume’’ of
this distribution is sufﬁciently small. If so, we consider the
gene to be differentially-expressed. A depiction of the
bivariate integral is shown in Fig. 2. Explicitly,
Fig. 1 Estimation of expression-independent error in a sample data
set. The estimation procedure computes parameters for a series of
expression-level quantile cutoffs. Array features with average mea-
surements below the cutoffs are discarded, and the most likely
parameters for the remaining data are computed. In this ﬁgure, each
point on the colored surface describes the estimated value of
expression-independent error (
ﬃﬃﬃﬃﬃ
^ B2
p
) for a given pair of cutoffs.
There are two rectangular regions where expression-independent error
appears to be stable. These regions are identiﬁed by arrows
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where pi is the joint posterior density for the ‘‘true’’
expression levels of the ith feature.
A solution to the integration of the bivariate normal is
given in Supporting Information Sect. III. When the
P-value is less than the signiﬁcance threshold, we reject the
null hypothesis that l1 = l2, and consider the difference in
gene expression to be statistically signiﬁcant. The results of
this test, when applied to a LPS-treated macrophage data
set, are shown in Fig. 3.
Specifying a signiﬁcance threshold
There are two commonly used methods for determining a
useful signiﬁcance threshold (a) when analyzing micro-
array data. If we are interested in maintaining an array-
wide false positive rate, we may set a Bonferroni-corrected
threshold (aBonf). This is equivalent to the number of fea-
tures we expect to appear as signiﬁcant by random chance
alone. If we set aBonf = 0.05, then we expect only one
feature to be signiﬁcant when analyzing 20 batches of
microarray experiments. Needless to say, this is a tre-
mendously strict signiﬁcance threshold. When the number
of features is large, the P-value threshold for a two-sided
test is
a ¼ aBonf=2n; ð6Þ
where n is the number of array features.
In some cases, the false discovery rate (FDR) may be
preferred. It is typically less stringent, but can still provide
meaningful results. Assuming that the P-value deﬁned here
gives a reasonable estimate for the type I error, the false
discovery rate is related to the array-wide false positive
rate by
FDR ¼
2n   a
i
¼
aBonf
i
; ð7Þ
where i is the number of signiﬁcant features.
Fig. 2 Depiction of the signiﬁcance integral. The statistical test
performed by BMA involves integration of a bivariate normal density.
The peak of the density appears on one side of the diagonal line. The
P-value is deﬁned as the ‘‘tail volume’’ on the side opposite of the
peak. Statistical signiﬁcance is achieved when the P-value is smaller
than a speciﬁed threshold. The bivariate normal density depicted in
(a) was sufﬁciently distant from the diagonal, and was considered a
‘‘signiﬁcant’’ change (aBonf = 0.05). The density depicted in (b) was
too close to the diagonal, and therefore does not represent a
signiﬁcant difference in gene expression
Fig. 3 A scatter plot demonstrating the results of BMA on macro-
phages treated with LPS for 1 h (aBonf = 0.05). Each point represents
the average signal measured from an array feature (n=2). High-
lighted dots appear farthest from the diagonal, indicating statistical
signiﬁcance
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123Results
Simulated data
We tested the accuracy of several statistical methods on
simulated data sets derived from the estimated variance
structure of a two-color data set recently published by
Rome et al. (2003). The authors analyzed the RNA con-
tent of human skeletal muscle biopsies collected before
and after application of a hyperinsulinemic euglycemic
clamp. Sample measurements for our simulated set were
obtained from lognormal distributions centered on the
pre-clamp mean intensities. The second treatment condi-
tion was obtained by ‘‘spiking’’ 10% of the features. The
sample means of these randomly selected features were
multiplied or divided by a random number between 1 and
20. Since the signal-to-noise ratio (SNR) is much greater
at higher signal intensities, it is likely that subtle changes
are more readily picked up at high levels of gene
expression. This model problem therefore contains both
subtle and dramatic gene expression changes at a variety
of intensity levels.
Prior to identifying the ‘‘spiked’’ features, we tested the
accuracy of two different modeling procedures. An
equivalent model for the variance structure of two-color
microarray data was previously proposed by Ideker et al.
(2000). We applied their modeling approach, VERA
(Variability and Error Assessment) along with our own, to
compare parameter accuracy (Fig. 4). Even with two rep-
licates, BMA showed striking accuracy in its estimate of
expression-independent variance. VERA underestimated
this parameter even with large replicate numbers (n = 16).
We attribute the accuracy of BMA to the cutoff procedure,
which reduces the effect of poor-quality measurements at
low intensities. Since expression-independent variance
dominates at low intensities, this precision is essential for
interpreting faintly-expressed genes. In addition, both
approaches had a tendency to underestimate expression-
dependent variance when only two replicates were used,
but improved with more replicates.
With these variance parameters, we then compared the
accuracy of four different methods in identifying ‘‘differ-
entially-expressed’’ genes. This comparison was performed
using three different thresholds of statistical signiﬁcance.
The quality of the predictions is displayed in Table 1. Each
of the statistical tests demonstrates improved sensitivity as
signiﬁcance thresholds were loosened and as larger num-
bers of experimental replicates were used. As we would
expect, the FDR signiﬁcance threshold was often predictive
of the true false-positive rate. There is only one clear case
where the false-positive rate substantially exceeded the
desired FDR. At n = 2 and FDR = 0.05, BMA shows a
loss in speciﬁcity. This results because expression-depen-
dent variance was underestimated at n = 2. When the
variance model derived from n = 6 data was used, the loss
of speciﬁcity was reversed. In all other cases, our method
appears to be much more sensitive than existing methods
without sacriﬁcing speciﬁcity.
These results show that BMA can accurately predict
genes that are differentially-expressed. The variance-
modeled approach is particularly beneﬁcial at low replicate
numbers where other statistical methods fail. In these
conditions, the variance model estimates variability more
accurately than traditional statistics. Applying this model
in a Bayesian framework translates into improved sensi-
tivity for subtle changes in gene expression.
Fig. 4 The variance structure estimated by BMA tightly ﬁts the
RMSD (root mean square deviation) as well as the underlying
variance model. The simulated data set shown here was obtained by
sampling from a ‘true’ model derived from the Rome et al. (2003)
two-color data set. The quality of ﬁt to RMSD is shown for a n = 2
and b n = 16 in non-transformed coordinates. The vertical dashed
line indicates the location of the quantile cutoff used to estimate the
variance parameters. The diagonal line labeled ‘‘Max RMSD’’ shows
the maximum possible value for RMSD at each expression level. The
variance model estimated by BMA tightly matches the ‘true’ model,
particularly at low intensities. This accuracy was not matched by
VERA and SAM, even when large numbers of replicates were used
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We also examined the effectiveness of our method along
with several others on two-channel microarray data avail-
able from the Alliance for Cellular Signaling (AfCS).
[Reference: http://www.signaling-gateway.org]. In this
data set, three pairs of dye-swapped measurements were
obtained for each of six time points during lipopolysac-
charide (LPS) treatment of RAW 264.7 macrophages, for a
total of 36 arrays. Data sets such as this are valuable for
understanding the dynamics of gene expression in response
to ligand. In addition, much is already known about the
behavior of macrophages in the presence of LPS. This is an
ideal system then, to determine whether it is possible to
interpret gene expression responses while using fewer
microarray replicates.
When all three dye-swap replicates are available, similar
setsofdifferentially-expressedgenescanbeobtainedbyany
of the previously described methods. At the 8 h time point,
for example, 1,492 genes were detected as differentially-
expressed by BMA, SAM, and Cyber-T (FDR = 0.001). In
contrast, only 300 were detected solely by BMA, 279 solely
Table 1 Simulated data sets of 20,000 features, 2,000 spiked genes were analyzed with four different methods to determine the accuracy of
predictions of differential-expression
Threshold Method TP FP FPR FNR Sensitivity Speciﬁcity
n=2
aBonf = 0.05 BMA 404 0 0.000 0.081 0.202 1.000
Cyber-T paired 78 0 0.000 0.096 0.039 1.000
kc = 23.8 VERA and SAM 274 9 0.032 0.088 0.137 1.000
FDR = 0.001 BMA 657 14 0.021 0.069 0.329 0.999
Cyber-T paired 139 0 0.000 0.094 0.070 1.000
SAM paired 0 0 N/A 0.100 0.000 1.000
FDR = 0.05 BMA 1,171 442 0.274 0.045 0.586 0.975
BMA (n=6 model) 472 5 0.010 0.078 0.236 1.000
Cyber-T paired 542 3 0.006 0.075 0.271 1.000
SAM paired 130 1 0.008 0.094 0.065 1.000
n=6
aBonf = 0.05 BMA 937 0 0.000 0.056 0.469 1.000
Cyber-T paired 269 0 0.000 0.088 0.135 1.000
kc = 23.8 VERA and SAM 1,155 4 0.003 0.045 0.578 1.000
FDR = 0.001 BMA 1,211 3 0.002 0.042 0.606 1.000
Cyber-T paired 387 0 0.000 0.082 0.194 1.000
SAM paired 0 0 N/A 0.100 0.000 1.000
FDR = 0.05 BMA 1,514 138 0.084 0.026 0.757 0.992
Cyber-T paired 925 2 0.002 0.056 0.463 1.000
SAM paired 266 8 0.029 0.088 0.133 1.000
n=1 6
aBonf = 0.05 BMA 1,479 3 0.002 0.028 0.740 1.000
Cyber-T paired 829 0 0.000 0.061 0.415 1.000
kc = 23.8 VERA and SAM 1,554 34 0.021 0.024 0.777 0.998
FDR = 0.001 BMA 1,589 16 0.010 0.022 0.795 0.999
Cyber-T paired 1,096 0 0.000 0.048 0.548 1.000
SAM paired 930 0 0.000 0.056 0.465 1.000
FDR = 0.05 BMA 1,718 160 0.085 0.016 0.859 0.991
Cyber-T paired 1,441 6 0.004 0.030 0.721 1.000
SAM paired 1,601 61 0.037 0.022 0.801 0.997
The number of true-positives (TP), number of false-positives (FP), false-positive rate (FPR), false-negative rate (FNR), sensitivity, and
speciﬁcity are reported for each method when either the Bonferroni-corrected threshold (aBonf) or false discovery rate (FDR) are controlled.
BMA demonstrates substantial improvements in sensitivity across all signiﬁcance thresholds investigated. A considerable loss of speciﬁcity was
only observed at low replicate numbers (n = 2) when the signiﬁcance threshold is loose (FDR = 0.05)
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tremendously with fewer array replicates, however. When
SAM is given fewer than three dye-swap pairs, no signiﬁ-
cance threshold can be found that satisﬁes the desired false-
discovery rate. With Cyber-T, similar to what is observed in
simulated data, far fewer numbers of signiﬁcant gene
expression changes are detected when either two dye-swap
pairs (n = 4) a single dye-swap pair (n = 2) are used
(Fig. 5). In contrast, our method detects similar numbers of
gene changes regardless of how many replicates are used in
analysis. This is further conﬁrmed by comparing the sets of
differentially expressed features (Figs. 6, 7). Despite using
only the information contained in a single dye-swap pair,
BMA identiﬁes equivalent sets of signiﬁcant changes. Fur-
thermore, we found that similar Gene Ontology (GO) terms
were statistically enrichedwhether we used asingledye pair
or all of the available data (Table 2). In particular, genes
involved in cell death and proliferation were strongly reg-
ulated by LPS. Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathways were also similarly enriched (Supporting
Information). Therefore, although increased sensitivity can
be gained byincreasingreplicate number, BMAallows usto
make meaningful biological interpretations of two-channel
functional genomics data with only a single dye-swap pair.
We further examined the 985 features that were
uniquely found by BMA with only two replicates at the 8 h
time point. Among these were 17 features associated with
components of the toll-like receptor signaling pathway as
deﬁned by KEGG. This list includes prominent ﬁgures
such as toll-like receptor 2 (Tlr2) and toll-like receptor 4
(Tlr4). Tlr4 is believed to be required for LPS-induced
signaling (Ulevitch and Tobias 1999), while expression of
Tlr2 and Tlr4 have previously been conﬁrmed to be
induced in murine alveolar macrophages by LPS (Oshik-
awa and Sugiyama 2003). Furthermore, it has long been
known that LPS stimulation induces macrophage expan-
sion in vivo (Yokochi et al. 1985). This effect on gene
expression is striking at the 8 h time point, as BMA found
115 additional features involved in cell proliferation. As
Fig. 5 BMA can use as little as a single pair of dye-swapped
measurements to identify an equivalent number of statistically
signiﬁcant gene expression changes in the LPS-treated RAW 264.7
data set at all six time points. The quantity of signiﬁcant gene changes
(aBonf = 0.05) stays relatively constant whether or not more repli-
cates are used. Cyber-T’s results approach BMAs as the number of
replicates increase Fig. 6 The identity of genes identiﬁed by BMA and Cyber-T are very
similar at the 8 h when all replicate data is used (n = 6). BMA also
obtains similar results when fewer replicates are used (n = 2). A
signiﬁcance threshold of aBonf = 0.05 was used for all methods
Fig. 7 The identity of genes identiﬁed by BMA, Cyber-T, and SAM
are similar at 8 h when all replicate data is used (n = 6). A
signiﬁcance threshold of FDR = 0.001 was used for all methods
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exogenous peptides, it is also interesting to note that seven
additional features involved in MHC class I and one
additional feature involved in MHC class II antigen pre-
sentation were also upregulated. This included several
HLA loci and b2-microglobulin. Class II MHCs are com-
monly thought to present exogenous antigens, but recent
evidence has shown that immunity against Mycobacterium
tuberculosis requires presentation on class I MHCs in a
‘detour’ pathway (Schaible et al. 2003). The consistency of
these results with known macrophage physiology is
strongly suggestive of the quality of genes detected by
BMA. Furthermore, these 985 features would have been
entirely missed by other methods if only two replicates
were used.
Discussion
In our analysis of the performance of BMA against present
statistical methods, BMA provides improved sensitivity at
all signiﬁcance thresholds and replicate numbers tested.
A loss of speciﬁcity was only observed in a simulated data
set when both (a) the variance model was not sufﬁciently
accurate and (b) a loose false discovery rate was desired. In
the LPS-treated macrophage data set, the signiﬁcant
features detected with three dye-swap replicates were not
substantially different from the features detected with a
single dye-swap replicate. Thus, a loss of speciﬁcity does
not appear be an issue when a stringent signiﬁcance
threshold is applied. In addition, since no additional
experiments need to be performed to compute this thresh-
old, our method is immediately applicable to existing data
sets.
The scope of microarray expression proﬁle studies has
been limited by the costs of producing sufﬁcient numbers
of arrays to accommodate present statistical methods.
BMA approaches this fundamental limitation by modeling
the relationships between variability and gene expression,
and applying this array-wide model as a more accurate
indicator of error. Although some previous attempts at
modeling the sources of noise have been described (Ideker
et al. 2000; Li and Wong 2001; Rocke and Durbin 2001),
much of the literature is devoted to ‘‘normalizing’’ array
data to reduce variability. While these forms of normali-
zation are not necessarily incompatible with BMA, we
believe they may actually introduce additional artifacts,
particularly when their assumptions are too strong. For
example, quantile and lowess normalization fail to account
for the poor signal-to-noise ratios at low intensities. When
we modeled variance parameters for unnormalized data, we
found a dramatic decrease in expression-independent
Table 2 Statistically enriched
GO terms among differentially-
expressed features after 1 h of
LPS treatment (BMA,
aBonf = 0.05)
The number of features
annotated with the GO term and
the P-value are also displayed.
Only the 10 GO terms with the
lowest P-values are shown. All
displayed GO terms are
signiﬁcantly enriched
(aBonf = 0.05). The complete
lists are provided in the
Supporting Information
GO ID GO term name Count P-value
n=2
GO:0006952 Defense response 46 0.0000000000
GO:0006954 Inﬂammatory response 20 0.0000000000
GO:0006955 Immune response 41 0.0000000000
GO:0009607 Response to biotic stimulus 48 0.0000000000
GO:0045087 Innate immune response 20 0.0000000000
GO:0009605 Response to external stimulus 51 0.0000000001
GO:0009611 Response to wounding 22 0.0000000001
GO:0009613 Response to pest/pathogen/parasite 24 0.0000000041
GO:0050896 Response to stimulus 53 0.0000000047
GO:0005125 Cytokine activity 22 0.0000000060
n=6
GO:0006952 Defense response 48 0.0000000000
GO:0006955 Immune response 44 0.0000000000
GO:0009607 Response to biotic stimulus 51 0.0000000000
GO:0009611 Response to wounding 25 0.0000000000
GO:0006954 Inﬂammatory response 21 0.0000000001
GO:0045087 Innate immune response 21 0.0000000001
GO:0006915 Apoptosis 30 0.0000000007
GO:0012501 Programmed cell death 30 0.0000000010
GO:0009613 Response to pest/pathogen/parasite 27 0.0000000021
GO:0009605 Response to external stimulus 54 0.0000000060
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dependent variance was slightly increased. More impor-
tantly though, we found that the expression-independent
correlation coefﬁcient (qB) converged on a more realistic
value, and was vastly more stable against quantile cutoffs.
This suggests to us that the underlying variance structure at
low intensities is clouded by these forms of normalization,
and that caution should be exercised in using these pro-
cedures. With BMA, meaningful results can be obtained
from raw data with minimal manipulation.
Furthermore, we believe that the current approaches for
normalizing variability may ultimately be limited by the
use of conventional statistical tests, which rely on large
levels of replication to demonstrate signiﬁcance. The levels
of replication demanded by these methods do not fre-
quently exist because of ﬁnancial and labor constraints.
They are even less likely to exist in multiple-ligand and
time-course studies. BMA takes advantage of the parallel
nature of microarrays to reduce replicate number. Two
channel arrays have tremendous untapped potential for
large-scale studies of functional genomics. We anticipate
that because of BMAs improved sensitivity at low replicate
numbers, it will provide (1) more consistent interpretations
of array data and (2) an avenue for implementing more
sophisticated experimental designs.
Conclusions
We have demonstrated here the effectiveness of our vari-
ance-modeled Bayesian approach on paired microarray
data. BMA provides improved sensitivity at all signiﬁcance
thresholds and replicate numbers tested. The present
method provides a reliable approach to identifying a set of
differentially-expressed features with an a priori-speciﬁed
signiﬁcance threshold. Since existing statistical tests are
unable to produce comparable results at low replicate
numbers, this represents a substantial advance in micro-
array statistics.
Methods
In order to assess the effectiveness of several current sta-
tistical approaches, we created a simulated data set based
on the error structure of the previously published data set of
Rome et al. (2003). We computed variance parameters
from this data set and used this model to generate random
paired-samplings from a lognormal density centered on the
sample means. The simulated data set contains 20,000
features. 10% of these features were randomly chosen to be
spiked by multiplying the sample mean by e
s, where s is a
sampling from a uniform random variate with support on
[-loge(20), loge(20)].
In our analysis with VERA and SAM (Ideker et al.
2000), we used a likelihood ratio cutoff of kc = 23.8 for
statistical signiﬁcance. For Cyber-T, we performed paired
analysis with m = 10, and detected signiﬁcance in two
ways: using aBonf = 0.05 and manually adjusting aBonf to
achieve the desired false-discovery rates of 0.001 and 0.05.
False-discovery rates in SAM were adjusted by adjusting D
until the desired FDR were achieved. For both versions of
BMA, we implemented an automated procedure that
identiﬁes the appropriate aBonf for the desired FDR, based
on golden section root ﬁnding. A lower bound for aBonf was
set at the minimum achievable FDR. The range of aBonf
was subsequently adjusted using Eq. 7 until aBonf could be
narrowed to within 10
-5. To determine the minimum
achievable FDR, we similarly used a golden section min-
imization strategy.
To demonstrate the effectiveness of each method on real
data, the AfCS LPS-treated RAW 264.7 Agilent inkjet-
deposited oligo data set was obtained from the AfCS web
site at http://www.signaling-gateway.org/. The processed
signal intensities were normalized with intensity-dependent
lowess normalization to standardize signals between
arrays, although similar results were obtained by BMA
without normalization. In order to identify a stable set of
variance parameters, a single variance model was obtained
from a pooled data set containing all six time points. This
model was then applied to all six time points to determine
differential expression.
Statistical enrichment of Gene Ontology terms and
KEGG pathways was computed by comparing the number
of ‘‘signiﬁcant’’ features annotated with a particular GO
term to the background. For the background, we used all of
the features on the Agilent array. Exact likelihoods
(P-values and q-values) were computed directly from the
hypergeometric distribution.
The modeling procedure and the bivariate microarray
analysis were implemented in a set of command-line JAVA
tools. These tools have been added to the VAMPIRE
(Variance-Modeled Posterior Inference with Regional
Exponentials) statistical package, and are available from
our website at http://genome.ucsd.edu/microarray. The
MCMC framework used in VAMPIRE and BMA is a
freely available JAVA package known as Hydra. The
CustomMetropolisHastingsSampler is used to carry out the
simulation, with a NormalMetropolisComponentProposal
generating potential states. In addition, we used the open
source library COLT for random number generation.
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